Nicolas Pasquier

Mr. Nicolas Pasquier

University of Turku
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JCJames Conway
James Conway
AIAleksi Isomursu
Aleksi Isomursu
GFGautier Follain
Gautier Follain
VHVille Härmä
Ville Härmä
EJEva Jou-Ollé
Eva Jou-Ollé
JIJohanna Ivaska
Johanna Ivaska
Integrin-dependent adhesion to the extracellular matrix (ECM) mediates mechanosensing and signaling in response to altered microenvironmental conditions. In order to provide tissue- and organ-specific cues, the ECM is composed of many different proteins that temper the mechanical properties and provide the necessary structural diversity. Despite most human tissues being soft, the prevailing view from predominantly in vitro studies is that increased stiffness triggers effective cell spreading and activation of mechanosensitive signaling pathways. To address the functional coupling of ECM composition and matrix rigidity on compliant substrates, we developed a matrix spot array system to screen cell phenotypes against different ECM mixtures on defined substrate stiffnesses at high resolution. We applied this system to both cancer and normal cells and surprisingly identified ECM mixtures that support stiffness-insensitive cell spreading on soft substrates. Employing the motor-clutch model to simulate cell adhesion on biochemically distinct soft substrates, with varying numbers of available ECM–integrin–cytoskeleton (clutch) connections, we identified conditions in which spreading would be supported on soft matrices. Combining simulations and experiments, we show that cell spreading on soft is supported by increased clutch engagement on specific ECM mixtures and even augmented by the partial inhibition of actomyosin contractility. Thus, “stiff-like” spreading on soft is determined by a balance of a cell’s contractile and adhesive machinery. This provides a fundamental perspective for in vitro mechanobiology studies, identifying a mechanism through which cells spread, function, and signal effectively on soft substrates.

20 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
QZQing Zhou
Qing Zhou
XSXiotian Sun
Xiotian Sun
NPNicolas Pasquier
Nicolas Pasquier
PJParvaneh Jefferson
Parvaneh Jefferson
Trang NguyenTrang Nguyen
Trang Nguyen
LGLloyd A. Greene
Lloyd A. Greene
Transcription factors are key players underlying cancer formation, growth, survival, metastasis and treatment resistance, yet few drugs exist to directly target them. Here, we characterized the in vitro and in vivo anti-cancer efficacy of novel synthetic cell-penetrating peptides (Bpep and Dpep) designed to interfere with the formation of active leucine-zipper-based dimers by CEBPB and CEBPD, transcription factors implicated in multiple malignancies. Both peptides similarly promoted apoptosis of multiple tumor lines of varying origins, without such effects on non-transformed cells. Combined with other treatments (radiation, Taxol, chloroquine, doxorubicin), the peptides acted additively to synergistically and were fully active on Taxol-resistant cells. The peptides suppressed expression of known direct CEBPB/CEBPD targets IL6, IL8 and asparagine synthetase (ASNS), supporting their inhibition of transcriptional activation. Mechanisms by which the peptides trigger apoptosis included depletion of pro-survival survivin and a required elevation of pro-apoptotic BMF. Bpep and Dpep significantly slowed tumor growth in mouse models without evident side effects. Dpep significantly prolonged survival in xenograft models. These findings indicate the efficacy and potential of Bpep and Dpep as novel agents to treat a variety of cancers as mono- or combination therapies.

1 March 2024 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
NPNicolas Pasquier
Nicolas Pasquier
FJFanny Jaulin
Fanny Jaulin
FPFlorent Peglion
Florent Peglion
Apicobasal epithelial polarity controls the functional properties of most organs. Thus, there has been extensive research on the molecular intricacies governing the establishment and maintenance of cell polarity. Whereas loss of apicobasal polarity is a well-documented phenomenon associated with multiple diseases, less is known regarding another type of apicobasal polarity alteration – the inversion of polarity. In this Review, we provide a unifying definition of inverted polarity and discuss multiple scenarios in mammalian systems and human health and disease in which apical and basolateral membrane domains are interchanged. This includes mammalian embryo implantation, monogenic diseases and dissemination of cancer cell clusters. For each example, the functional consequences of polarity inversion are assessed, revealing shared outcomes, including modifications in immune surveillance, altered drug sensitivity and changes in adhesions to neighboring cells. Finally, we highlight the molecular alterations associated with inverted apicobasal polarity and provide a molecular framework to connect these changes with the core cell polarity machinery and to explain roles of polarity inversion in health and disease. Based on the current state of the field, failure to respond to extracellular matrix (ECM) cues, increased cellular contractility and membrane trafficking defects are likely to account for most cases of inverted apicobasal polarity.

21 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NPNicolas Pasquier
Nicolas Pasquier
AIAleksi Isomursu
Aleksi Isomursu
HHHellyeh Hamidi
Hellyeh Hamidi
JMJacques R.R. Mathieu
Jacques R.R. Mathieu
JHJouni Härkönen
Jouni Härkönen
JIJohanna Ivaska
Johanna Ivaska
Mucinous colorectal carcinoma (MUC CRC) dissemination into the tumor stroma and metastasis to multiple organs, including the peritoneum, is associated with poor prognosis. Disseminating MUC CRCs exhibit either a conventional ‘apical-in’ or an inverted ‘apical-out’ polarity phenotype that influence patient outcome. Identifying the mechanisms controlling MUC CRC polarity is critical to understand disease progression. Here, we analyze patient-derived MUC CRC xenografts, with apical-in or apical-out polarity, ex vivo or within collagen gels to mimic the peritumoral stroma. Single-cell analyses reveal α2β1-integrin as a key collagen-binding receptor in these models. Collagen–α2β1-integrin interaction activates Src and ERK/MAPK signaling and upregulates the expression of SorLA, an endosomal sorting receptor. SorLA supports apical-in polarity and carcinoma-stroma interactions by promoting integrin recycling to the plasma membrane and HER2/HER3 expression through a positive feedback mechanism. Accordingly, we observe positive correlation between HER2, HER3 and SorLA in patient samples with the highest HER2 expression in apical-in-presenting tissues. Treatment of tumor spheres with clinically relevant HER2/HER3-targeting antibodies reverts sphere polarity and impedes collagen remodeling and adhesion to mouse peritoneum. This SorLA—integrin—HER2/HER3 signaling axis may represent a basis for MUC CRC-patient stratification and shed light on other carcinomas with similar apical-out phenotypes.

8 April 2026
Verified
Thesis
Closed access
NPNicolas Pasquier
Nicolas Pasquier
Rôle des intégrines dans la régulation de la polarité apicobasale, l'architecture cellulaire et la progression cancéreuse: Les intégrines sont des protéines régulant l'adhésion, la migration et l'architecture cellulaires, jouant un rôle tant dans le développement des tissus sains que dans la progression cancéreuse. Bien que les intégrines aient été largement étudiées dans divers modèles biologiques, la manière dont leur disponibilité agit sur la polarité apicobasale, la migration et la capacitation cellulaires n'est pas entièrement connue à ce jour.Ici, nous étudions le rôle des intégrines, et principalement de l'intégrine-β1, sur l'établissement de la polarité apicobasale ainsi que sur la migration cellulaire dans des modèles cancéreux. Nous décryptons également leur action sur l'établissement de l'identité cellulaire en étudiant leur rôle dans la capacitation des cellules souches pluripotentes induites humaines (hiPSCs).Les résultats de cette thèse permettent d'identifier une nouvelle une boucle de recyclage de l'intégrine-β1, dépendante de SorLA, HER2 et HER3, permettant aux cellules de cancer du côlon de percevoir la matrice et d'orienter leur polarité apicobasale. Nous approfondissons également la compréhension de la migration de cellules cancéreuses sur la matrice extra-cellulaire en identifiant deux compositions matricielles (collagène + laminine et laminine + ténascine C) permettant aux cellules cancéreuses d'ostéosarcome et aux fibroblastes de migrer indépendamment de la rigidité du substrat grâce à une augmentation du nombre de points d'ancrage moléculaires impliquant l'intégrine-β1. Nous investiguons également le rôle de l'intégrine-β1 dans le processus de capacitation des cellules souches et montrons que l'inhibition de l'intégrine-β1 maintient un phénotype similaire à l'état naïf chez les hiPSCs.Ensemble, ces données soulignent l'importance des intégrines, et principalement de l'intégrine-β1, dans de nombreux processus cellulaires parmi les modèles, expliquant ainsi son importance dans l'adhésion cellulaire, l'architecture des cellules cancéreuses ainsi que dans l'établissement de l'identité cellulaire.